Paul Tudor Jones Amgen Inc Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Amgen Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 57,091 shares of AMGN stock, worth $17.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

57,091

Previous 50,355 13.38%

Holding current value

$17.2 Million

Previous $15.7 Million 1.61%

% of portfolio

0.04%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$262.28 - $309.85 $1.77 Million - $2.09 Million	6,736 Added 13.38%	57,091 $15.9 Million
Q1 2025 May 15, 2025	SELL	$258.59 - $327.36 $2.28 Million - $2.89 Million	-8,814 Reduced 14.9%	50,355 $15.7 Million
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $15.3 Million - $19.4 Million	59,169 New	59,169 $15.4 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $44.2 Million - $53.4 Million	164,400 New	164,400 $46.7 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $16.9 Million - $20 Million	-78,777 Reduced 80.89%	18,616 $4.13 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $22 Million - $26.8 Million	97,393 New	97,393 $23.5 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.65 Million - $1.84 Million	7,160 Added 155.01%	11,779 $2.87 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.01 Million - $1.12 Million	4,619 New	4,619 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $893,170 - $1.02 Million	-4,491 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $291,022 - $340,967	-1,371 Reduced 23.39%	4,491 $955,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $1.37 Million - $1.52 Million	5,862 New	5,862 $1.43 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.74 Million - $1.94 Million	-7,423 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $665,432 - $816,577	-3,364 Reduced 31.19%	7,423 $1.75 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $92,395 - $122,541	-507 Reduced 4.49%	10,787 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $2.14 Million - $2.75 Million	11,294 New	11,294 $2.72 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $396,796 - $475,444	-2,279 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $6 Million - $7.04 Million	-36,014 Reduced 94.05%	2,279 $420,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $6.93 Million - $7.81 Million	38,293 New	38,293 $7.28 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $3.06 Million - $3.45 Million	-16,497 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $1.45 Million - $1.63 Million	-8,757 Reduced 34.68%	16,497 $3.05 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $2.63 Million - $3.08 Million	15,538 Added 159.92%	25,254 $4.31 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.64 Million - $1.83 Million	9,716	9,716 $1.69 Million

Others Institutions Holding AMGN

# of Institutions

3,280

Shares Held

441M

Call Options Held

6.14M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $161B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account